{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:01:23Z","timestamp":1791615683950,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.micpath.2023.106425","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T17:51:32Z","timestamp":1698861092000},"page":"106425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["A novel mRNA rabies vaccine as a promising candidate for rabies post-exposure prophylaxis protects animals from different rabies viruses"],"prefix":"10.1016","volume":"185","author":[{"given":"Peng-Cheng","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3183-9506","authenticated-orcid":false,"given":"Sheng-Li","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Yu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoye","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Fei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Li","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu-Yang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.micpath.2023.106425_bib1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-virology-100114-055157","article-title":"Everything you always wanted to know about rabies virus (but were afraid to ask)","volume":"2","author":"Davis","year":"2015","journal-title":"Annu. Rev. Virol."},{"issue":"4","key":"10.1016\/j.micpath.2023.106425_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrmicro.2018.11","article-title":"The spread and evolution of rabies virus: conquering new frontiers","volume":"16","author":"Fisher","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"issue":"4","key":"10.1016\/j.micpath.2023.106425_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003709","article-title":"Alliance for rabies control partners for rabies, estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2023.106425_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4049\/jimmunol.110.1.269","article-title":"Antigenic properties of rabies virus components","volume":"110","author":"Wiktor","year":"1973","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.micpath.2023.106425_bib5","article-title":"Novel vaccines to human rabies","volume":"3","author":"Rupprecht","year":"2009","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"3","key":"10.1016\/j.micpath.2023.106425_bib6","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/iai.16.3.754-759.1977","article-title":"Rabies virus glycoprotein. II. Biological and serological characterization","volume":"16","author":"Cox","year":"1977","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.micpath.2023.106425_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JVI.01342-07","article-title":"Double-labeled rabies virus: live tracking of enveloped virus transport","volume":"82","author":"Klingen","year":"2008","journal-title":"J. Virol."},{"issue":"37","key":"10.1016\/j.micpath.2023.106425_bib8","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1016\/j.vaccine.2018.06.061","article-title":"Rabies vaccines: WHO position paper, April 2018 - recommendations","volume":"36","author":"World Health","year":"2018","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.micpath.2023.106425_bib9","first-page":"109","volume":"77","year":"2002","journal-title":"Rabies vaccines"},{"issue":"Suppl 1","key":"10.1016\/j.micpath.2023.106425_bib10","doi-asserted-by":"crossref","first-page":"A140","DOI":"10.1016\/j.vaccine.2018.08.039","article-title":"New human rabies vaccines in the pipeline","volume":"37","author":"Fooks","year":"2019","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.micpath.2023.106425_bib11","article-title":"Advances in RNA vaccines for preventive indications: a case study of A vaccine against rabies","volume":"7","author":"Armbruster","year":"2019","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.micpath.2023.106425_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.micpath.2023.106425_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41541-021-00307-6","article-title":"Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates","volume":"6","author":"Saunders","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.micpath.2023.106425_bib14","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1038\/s41467-018-05482-0","article-title":"Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies","volume":"9","author":"Pardi","year":"2018","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.micpath.2023.106425_bib15","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA vaccines protect against zika virus infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.micpath.2023.106425_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-3099(20)30843-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Zhang","year":"2021","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2023.106425_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-022-00950-y","article-title":"Advances in COVID-19 mRNA vaccine development","volume":"7","author":"Fang","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.micpath.2023.106425_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.micpath.2023.106425_bib19","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.ymthe.2022.02.016","article-title":"COVID-19 mRNA vaccines: platforms and current developments","volume":"30","author":"Szabo","year":"2022","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.micpath.2023.106425_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/v14020401","article-title":"mRNA vaccine development for emerging animal and zoonotic diseases","volume":"14","author":"Le","year":"2022","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.micpath.2023.106425_bib21","article-title":"mRNA innovates the vaccine field","volume":"9","author":"Pardi","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"3\u20134","key":"10.1016\/j.micpath.2023.106425_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41434-020-00204-y","article-title":"Self-amplifying RNA vaccines for infectious diseases","volume":"28","author":"Bloom","year":"2021","journal-title":"Gene Ther."},{"issue":"8","key":"10.1016\/j.micpath.2023.106425_bib23","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1128\/jvi.65.8.4198-4203.1991","article-title":"Antigenicity of rabies virus glycoprotein","volume":"65","author":"Benmansour","year":"1991","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.micpath.2023.106425_bib24","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/jvi.53.3.926-934.1985","article-title":"Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein","volume":"53","author":"Seif","year":"1985","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.micpath.2023.106425_bib25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/viro.1993.1261","article-title":"Mechanisms of rabies virus neutralization","volume":"194","author":"Flamand","year":"1993","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.micpath.2023.106425_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007036","article-title":"The reemergence of human rabies and emergence of an Indian subcontinent lineage in Tibet, China","volume":"13","author":"Tao","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.micpath.2023.106425_bib27","first-page":"491","article-title":"Differences on geographic distribution of rabies virus lineages in China","volume":"4","author":"Wang","year":"2018","journal-title":"Chin. J. Epidemiol."},{"issue":"12","key":"10.1016\/j.micpath.2023.106425_bib28","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nbt.2436","article-title":"Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection","volume":"30","author":"Petsch","year":"2012","journal-title":"Nat. Biotechnol."},{"issue":"10","key":"10.1016\/j.micpath.2023.106425_bib29","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.tim.2007.09.003","article-title":"The benefits of using diverse animal models for studying pertussis","volume":"15","author":"Elahi","year":"2007","journal-title":"Trends Microbiol."},{"issue":"1","key":"10.1016\/j.micpath.2023.106425_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.antiviral.2013.01.003","article-title":"Current and future approaches to the therapy of human rabies","volume":"99","author":"Jackson","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.micpath.2023.106425_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fvets.2017.00009","article-title":"Elimination of dog-mediated human rabies deaths by 2030: needs assessment and alternatives for progress based on dog vaccination","volume":"4","author":"Wallace","year":"2017","journal-title":"Front. Vet. Sci."},{"issue":"10","key":"10.1016\/j.micpath.2023.106425_bib32","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.4161\/hv.25181","article-title":"A novel, disruptive vaccination technology: self-adjuvanted RNActive((R)) vaccines","volume":"9","author":"Kallen","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"issue":"6","key":"10.1016\/j.micpath.2023.106425_bib33","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/wrna.1189","article-title":"Messenger RNA-based vaccines: progress, challenges, applications","volume":"4","author":"Kramps","year":"2013","journal-title":"Wiley Interdiscipl. Rev. RNA"},{"issue":"6","key":"10.1016\/j.micpath.2023.106425_bib34","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2217\/17460913.2.6.667","article-title":"Use of animal models in the development of human vaccines","volume":"2","author":"Gerdts","year":"2007","journal-title":"Future Microbiol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401023004588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401023004588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:05:13Z","timestamp":1760112313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401023004588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":34,"alternative-id":["S0882401023004588"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2023.106425","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel mRNA rabies vaccine as a promising candidate for rabies post-exposure prophylaxis protects animals from different rabies viruses","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2023.106425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106425"}}